BAY City Capital LLC
SEC-identified person · CIK 1288452 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Synta Pharmaceuticals Corp SNTA | Director | filed 2016 - 2021 |
| Xilio Therapeutics, Inc. XLO | Officer | filed 2021 - 2021 |
| Imara Inc. IMRA | Officer | filed 2020 - 2020 |
| Kezar Life Sciences, Inc. KZR | Officer | filed 2018 - 2018 |
| Interleukin Genetics INC ILIU | Officer | filed 2013 - 2016 |
| Epizyme, Inc. EPZM | Officer | filed 2013 - 2016 |
| Viracta Therapeutics, Inc. VIRX | Officer | filed 2009 - 2015 |
| Nevro Corp NVRO | Officer | filed 2014 - 2015 |
| Dermira, Inc. DERM | Director | filed 2014 - 2014 |
| Hyperion Therapeutics INC HPTX | Officer | filed 2012 - 2013 |
| Reshape Weightloss Inc. etrm | Officer | filed 2007 - 2011 |
| VIA Pharmaceuticals, Inc. VIAP | Officer | filed 2007 - 2010 |
| Poniard Pharmaceuticals, INC. PARD | Officer | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.